Pro-inflammatory cytokines, such as IL-6 and TNF-α, promote tumor cell survival by activating anti-apoptotic pathways, thereby increasing osteosarcoma cells’ resistance to therapeutic interventions. This evidence concerns the gene IL6 and osteosarcoma.